How much funding has Surglasses raised?

Surglasses has raised $6.5M in total funding, most recently a Series A round.

Who are Surglasses's investors?

Surglasses's investors include Taiwania Capital, Integrated Capital, 500 Global, Wisdom Ventures.

Where is Surglasses headquartered?

Surglasses is headquartered in Taichung, Taiwan.

What industry is Surglasses in?

Surglasses operates in Healthcare, Medtech.

How many employees does Surglasses have?

Surglasses has 11-50 employees.

Surglasses

Taichung, Taiwan · $6.5M raised

Healthcare

Medtech

Headquarters: Taichung
Employees: 11–50
Business Model: B2B
Website: surglasses.com

Total Funding: $6.5M
Last Round: $6.5M Series ANov 2023
Rounds: 1

About

Surglasses (Taiwan Main Orthopaedic Biotechnology) develops AR and mixed reality smart surgical eyewear for spinal and orthopedic navigation. Its flagship product, Caduceus S, is FDA 510(k) cleared, TFDA and EU CE certified, and has been used in the first AR-guided spine surgeries in the United States. The company targets hospital systems and surgical education institutions globally.

Summary

Surglasses is a Healthcare company based in Taichung, Taiwan. It has raised $6.5M in total across 1 round, most recently a $6.5M Series A round in Nov 2023. Investors include Taiwania Capital, Integrated Capital and 500 Global.